(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) rising 15.8% to €9.82 on Monday while BEL 20 fell 0.44% to €3,655.73.
NYXOAH’s last close was €8.48, 8.42% below its 52-week high of €9.26.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.76%.
More news about NYXOAH (NYXH.BR).
